HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B-Cell Receptor Features and Database Establishment in Recovered COVID-19 Patients by Combining 5'-RACE with PacBio Sequencing.

AbstractBACKGROUND:
Antibodies induced by viral infection can not only prevent subsequent virus infection, but can also mediate pathological injury following infection. Therefore, understanding the B-cell receptor (BCR) repertoire of either specific neutralizing or pathological antibodies from patients convalescing from Coronavirus disease 2019 (COVID-19) infection is of benefit for the preparation of therapeutic or preventive antibodies, and may provide insight into the mechanisms of COVID-19 pathological injury.
METHODS:
In this study, we used a molecular approach of combining 5' Rapid Amplification of cDNA Ends (5'-RACE) with PacBio sequencing to analyze the BCR repertoire of all 5 IgH and 2 IgL genes in B-cells harvested from 35 convalescent patients after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
RESULTS:
We observed numerous BCR clonotypes within most COVID-19 patients, but not in healthy controls, which validates the association of the disease with a prototypical immune response. In addition, many clonotypes were found to be frequently shared between different patients or different classes of antibodies.
CONCLUSIONS:
These convergent clonotypes provide a resource to identify potential therapeutic/prophylactic antibodies, or identify antibodies associated with pathological effects following infection with SARS-CoV-2.
AuthorsZhu Zhu, Pingzhang Wang, Xiaodong Jia, Meng Yu, Huige Yan, Lei Liu, Wanbing Liu, Yaqiong Zheng, Guomei Kou, Jie Wang, Weiyan Xu, Jing Huang, Fugang Duan, Fengmin Lu, Ning Fu, Ning Zhang, Yingying Lu, Hui Dai, Shangen Zheng, Xiaoyan Qiu
JournalFrontiers in bioscience (Landmark edition) (Front Biosci (Landmark Ed)) Vol. 28 Issue 2 Pg. 40 (02 28 2023) ISSN: 2768-6698 [Electronic] Singapore
PMID36866541 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2023 The Author(s). Published by IMR Press.
Chemical References
  • Receptors, Antigen, B-Cell
  • Antibodies
Topics
  • Humans
  • COVID-19
  • SARS-CoV-2
  • Receptors, Antigen, B-Cell (genetics)
  • Antibodies
  • B-Lymphocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: